Loading patent…
OwnerRosario Perona Abellon, Leandro Sastre Garzon +2inventors
InventorsRosario Perona Abellon, Leandro Sastre Garzon, Rosario Machado Pinilla, Isabel Sanchez Perez
Estimating the term…
This invention describes the use of an inductor or activator compound GSE24.2 for producing a medicament or pharmaceutical composition for treating a preferably human illness or pathological situation caused by a senescence process. Said pharmaceutical composition can be useful for a treatment of tissue regeneration, for example of epithelial tissues or haematopoietic cells, and also for the immortalisation of eukaryote cells for use of same in biotechnological research or processes.
A method of treatment or prevention for a human illness or pathological situation caused by a process of altered senescence, comprising administration of a therapeutically effective amount of a pharmaceutical composition which comprises an inductor or activator compound GSE 24.2.
A pharmaceutical composition for treating an illness or pathology related to alterations of senescence, wherein the pharmaceutical composition comprises GSE 24.2 in a therapeutically effective quantity along with a pharmaceutically acceptable carrier.
(canceled)
A eukaryotic cell characterized in that it presents a reversed or diminished process of senescence and in that it comprises the element GSE24.2.
Dependencies are inferred from the claim text.